Baillie Gifford started to build up the position in Accelerate Diagnostics in Q4 2020 and continued to invest until Q1 2021. Since then they sold 41 shares. The investor sold all their shares in Q2 2023 and doesn't own any shares in Accelerate Diagnostics anymore.